YH-36425

N/A

Report date: 2023/03/05 19:04:07

Base Information

Drug NameYH-36425

Drug Alias NameYH36425

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCeramide glucosyltransferase inhibitors

TargetsCeramide glucosyltransferase

Therapy Area/IndicationsFabry Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesYuhan Corp

China Registration ClassN/A

Active CompaniesYuhan Corp

Inactive CompaniesN/A

Active IndicationsFabry Disease

Inactive IndicationsN/A

ATC CodeN/A